Project Grant HT9425261E094
- Federal Grant Award Summary The Defense Health Agency (DHA) awarded The Trustees of Columbia University in the City of New York's Health Sciences Division a $1.645 million Project Grant under the Military Medical Research and Development program (CFDA 12.420) effective July 1, 2025, through June 30, 2028. The award supports research on treating HER2 therapy-resistant brain metastasis using antidepressants, conducted at Columbia's Health Sciences Division facility in New York, NY. This project...
- Federal Project Grant Award Summary Columbia University's Health Sciences Division received a $750,000 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) with a performance period from July 1, 2026 through June 30, 2029. The award funds research to identify novel therapeutic targets that overcome treatment resistance in triple-negative breast cancer (TNBC), a particularly aggressive form of cancer with limited...
- Federal Project Grant Award Summary The Trustees of Columbia University in the City of New York, Health Sciences Division, received a $1.645 million Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) effective May 1, 2025, through April 30, 2028. The award funds research investigating bone fracture-induced joint bleeding and its role in posttraumatic osteoarthritis development. This research aligns with the DHA's mission...
- Federal Project Grant Award Summary Columbia University's Health Sciences Division received a $1.6M Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) effective July 1, 2025, through June 30, 2028. The award supports research investigating the role of Streptococcus in esophageal neoplasia, with research activities conducted at the institution's facilities in New York, NY. This three-year funded initiative falls within...
- Federal Grant Award Summary The Defense Health Agency (DHA) awarded The Trustees of Columbia University in the City of New York—Health Sciences Division a $218,055 Project Grant under the Military Medical Research and Development program (CFDA 12.420) effective August 1, 2025, with a completion date of July 31, 2028. The award funds research titled "Enhancing Early Detection of Pancreatic Cancer Using GPT-Embedded EHR Models: A Novel Approach for Improved Predictive Performance and...
- Federal Grant Award Summary The Trustees of Columbia University in the City of New York, Health Sciences Division, received a $822,499 Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) effective August 15, 2025, with completion targeted for August 14, 2028. The award supports research investigating the role of methionine oxidation in cancer-associated cachexia, a condition characterized by progressive muscle and...
- The Defense Health Agency awarded a $1,316,000 Project Grant to The Trustees of Columbia University in the City of New York (Health Sciences Division) on August 1, 2025 through the Military Medical Research and Development program (CFDA 12.420). The funding supports a 4-year research project titled "ADVANCING WRN AS A PROMISING THERAPEUTIC TARGET FOR MSI-H CANCERS" to conduct advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the...
- Federal Project Grant Summary The Trustees of Columbia University in the City of New York, Health Sciences Division, received a $650,000 Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) for research on psychiatric aspects of post-traumatic epilepsy. The award, dated April 15, 2025, supports a three-year performance period through April 14, 2028, with performance conducted at Columbia's New York, NY location. This...
- Federal Grant Award Summary The Defense Health Agency awarded Columbia University's Health Sciences Division a $301,632 Project Grant under the Military Medical Research and Development program (CFDA 12.420) effective August 1, 2026, with completion targeted for July 31, 2029. The project, titled "The Value of Hypertension Control to Prevent Dementia and Enhance Readiness: Generating Evidence from DOD-VHA Data, Patient Preferences and Health Economics," will deliver evidence-based...
- The Trustees of Columbia University in the City of New York, doing business as Health Sciences Division, was awarded a $656,272 Project Grant by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant supports research aimed at optimizing PD-1 immunotherapy through increased T cell regeneration and reduced antigen load. This 2-year project will be conducted in New York, NY from September 1, 2023 to August 31, 2025. The Military Medical...
The Defense Health Agency (DHA) awarded The Trustees of Columbia University in the City of New York a $1,099,932 Project Grant under the Military Medical Research and Development program (CFDA 12.420) effective June 1, 2026, through May 31, 2030. The award supports research focused on optimization of targeted drug delivery and radiosensitizing strategies for pediatric diffuse midline glioma, a critical area aligned with the DHA's mission to transform healthcare for service members and the American public through innovative biomedical research solutions. Research activities will be conducted at Columbia University's Health Sciences Division in New York, leveraging the institution's substantial expertise in translational medicine, cancer research, and clinical investigation. Under this Military Medical Research and Development program award, Columbia University will deliver hypothesis-driven research and development services addressing this pediatric oncology challenge through a four-year performance period. The project represents the DHA's investment in advancing therapeutic approaches for a significant childhood brain tumor malignancy through basic and applied research that advances military health priorities and broader public health objectives, consistent with the program's emphasis on innovative cancer research solutions and translational investigation.Federal Project Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $1.1m | 3/30/26 |